Archives
Cell & Gene Therapy (CGT)
The CGT market is set to grow significantly with new payment models addressing cost concerns.
Evolution of GLP-1s
The use of GLP-1s continues its meteoric rise, with expanded impact but also some negative outcomes.
Alternative Individual Products
2025 will see an emphasis on flexible health insurance options.
Make America Healthy Again
The new administration may prioritize food and lifestyle change to improve population health.
Private Equity Scrutiny
Continued scrutiny on private equity-backed healthcare delivery organizations will cause irreparable damage.
The Workforce Cliff
Ongoing workforce shortages and physician burnout are driving AI use and development.
Rise of Misinformation
Misinformation about healthcare will continue to challenge trust.
Capital Markets Thaw
Capital markets activity will increase as the healthcare industry stabilizes.